NCT04808778View on ClinicalTrials.gov

Stroke Prevention in Young Adults With Sickle Cell Anemia

Active, not recruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

May 17, 2021

Primary Completion Date

June 1, 2029

Study Completion Date

June 1, 2029

Conditions
Sickle Cell DiseaseSickle Cell AnemiaStroke, IschemicSilent StrokeSilent Cerebral InfarctStroke
Interventions
DRUG

Hydroxyurea therapy per standard care

Moderate-dose of 20mg/kg/day

Trial Locations (2)

37232-9000

Vanderbilt University Medical Center, Nashville

Unknown

Aminu Kano Teaching Hospital, Kano

All Listed Sponsors
collaborator

Aminu Kano Teaching Hospital

OTHER

lead

Vanderbilt University Medical Center

OTHER